US Broker Ratings

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Exploring a 38% Upside Potential in the Biotech Sector

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing significant attention from investors, thanks to its promising clinical-stage developments and a substantial market cap of $2.91 billion. As..

Dynavax Technologies (DVAX) Investor Outlook: Analyzing a 33% Potential Upside in the Biopharma Sector

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the healthcare sector, is making waves with its promising vaccine developments and a notable 33.38% potential upside,..

Harrow, Inc. (HROW) Stock Analysis: A Promising 39% Upside Potential in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may want to consider Harrow, Inc. (NASDAQ: HROW), a dynamic player in the ophthalmic pharmaceutical industry. Currently priced at..

The Pennant Group, Inc. (PNTG): Investor Outlook with a 24.30% Upside Potential

The Pennant Group, Inc. (NASDAQ: PNTG) is capturing the attention of individual investors, particularly those with an interest in the healthcare sector. With its current market..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook with a Promising 27.39% Upside Potential

Aveanna Healthcare Holdings Inc (NASDAQ: AVAH) is capturing investor attention with its robust growth trajectory and compelling potential upside of 27.39%, as indicated by current analyst..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: A Biotech Contender with a 4.89% Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is making waves in the biotechnology sector with its focus on developing therapies for autoimmune diseases. With a market capitalization of..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating a Complex Market with a 7.47% Potential Upside

10x Genomics, Inc. (NASDAQ: TXG), a key player in the healthcare sector, specializes in health information services, offering innovative solutions for analyzing biological systems. Headquartered in..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: A 10.73% Potential Upside Amidst Robust Revenue Growth

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is capturing attention in the biotechnology sector with its promising developments in dermatological disease treatments. Headquartered in Westlake Village, California, this..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A Prescription for Growth with 9.75% Upside Potential

Guardian Pharmacy Services, Inc (NASDAQ: GRDN), a prominent player in the healthcare sector, is gaining investor attention with its specialized services in medical care facilities across..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 49.59% Upside Potential

Astrana Health Inc. (ASTH), a prominent player in the healthcare sector, is worth a close look by investors seeking opportunities in the medical care facilities industry...

Neogen Corporation (NEOG) Stock Analysis: Evaluating the 13% Upside Potential

Neogen Corporation (NASDAQ: NEOG) stands as a notable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Lansing, Michigan, Neogen has..

Evolent Health, Inc. (EVH) Stock Analysis: Evaluating a Promising 150% Potential Upside

Evolent Health, Inc. (NASDAQ: EVH) stands out in the healthcare sector, particularly within the health information services industry, as a company with a compelling narrative for..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 46% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a key player in the biotechnology sector, is drawing significant attention from investors, thanks to its robust product lineup and promising market..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 14% Potential Upside in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) occupies a unique niche within the healthcare sector, focusing on the development and distribution of non-opioid pain management solutions. With a..

Clover Health Investments (CLOV): A 30% Upside Potential Amidst Revenue Growth and Market Volatility

Clover Health Investments, Corp. (NASDAQ: CLOV) is drawing attention in the healthcare sector with its notable 30.38% potential upside, as indicated by the average analyst target..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Exploring a 9.25% Upside Potential in the Healthcare Sector

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leader in the medical devices industry, is gaining attention from investors for its innovative approach to aesthetic and reconstructive..

Wave Life Sciences Ltd. (WVE) Stock Analysis: Uncovering the 76.93% Upside Potential for Investors

Wave Life Sciences Ltd. (WVE), a pioneering biotechnology company headquartered in Singapore, is captivating the attention of investors with its promising 76.93% potential upside. As a..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 55% Upside Potential in the Healthcare Sector

Pulse Biosciences, Inc (NASDAQ: PLSE) is generating buzz among investors with its promising position in the healthcare sector. Specializing in medical instruments and supplies, this Miami-based..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a Potential 18.38% Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, is gaining attention for its promising stock performance and growth potential. With a market..

Beam Therapeutics Inc. (BEAM) Stock Analysis: A Promising 64.97% Upside Potential Draws Investor Attention

Beam Therapeutics Inc. (NASDAQ: BEAM), a pioneering biotechnology company based in Cambridge, Massachusetts, is gaining significant traction among investors due to its innovative approach to developing..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds